stockrowColgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
Follow CL
Alert me
Colgate-Palmolive Company (CL) EPS (diluted)
Colgate-Palmolive Company's EPS (diluted) for fiscal 2025 was $2.63, down 25.1% from $3.51 in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.58. Over the past ten years it has ranged from $1.52 (fiscal 2015) to $3.51 (fiscal 2024); the current reading is higher than 45% of that period. Colgate-Palmolive Company ranks 7th of 26 Household & Personal Products companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $2.63 | (25.07%) |
| FY2024 | $3.51 | 26.71% |
| FY2023 | $2.77 | 30.05% |
| FY2022 | $2.13 | (16.47%) |
| FY2021 | $2.55 | (18.79%) |
| FY2020 | $3.14 | 14.18% |
| FY2019 | $2.75 | 0.00% |
| FY2018 | $2.75 | 20.61% |
| FY2017 | $2.28 | (16.18%) |
| FY2016 | $2.72 | 78.95% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.97 | 13.27% |
| Jun 2026 | $0.86 | 7.50% |
| Mar 2026 | $0.80 | — |
| Dec 2025 | −$0.05 | — |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| PG Procter & Gamble Company (The) compare | $6.52 |
| KMB Kimberly-Clark Corporation compare | $5.88 |
| CLX The Clorox Company compare | $5.56 |
| CHD Church & Dwight Co., Inc. compare | $3.25 |
| CL Colgate-Palmolive Company | $2.58 |
| ELF e.l.f. Beauty compare | $1.00 |
| EL The Estee Lauder Companies Inc. compare | $1.00 |
| KVUE Kenvue Inc. compare | $0.88 |
| UL Unilever PLC compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement